Actually after some thought.
What bio markers were identified that led the team to utilise Remestemcel-l for heart conditions in the pediatric space.
Huh - FDA- REM-l works against SR-aGVHD in
kids under 12.
Huh - FDA- REM-l works against Covid-19 Mis-C in children, actually no, let be more specific . The kids in danger of imminent heart failure receive REM-l and are just dandy in a couple of days.
Soon , FDA, you will be tapped with the secondary endpoint data for the randomised double blind trial.
There’s not a big enough rock for the current review team to hide under denying a safe treatment that works. .
Reg
Tic Toc
Cell Therapy News/Articles, page-8289
-
- There are more pages in this discussion • 9,755 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |